ELC Group appoints Head of Regulatory Affairs for Russia and CIS ELC Group appoints Head of Regulatory Affairs for Russia and CIS Inna Demidova to head new Moscow office for global regulatory affairs specialist Concept Life Sciences appoints Matthew Jones as Chief Commercial Officer Concept Life Sciences appoints Matthew Jones as Chief Commercial Officer Jones has two decades of experience in the life sciences industry PCI welcomes Director of Project Management to its clinical services group PCI welcomes Director of Project Management to its clinical services group Tim Brown joins the North American Clinical Services team Alexander Wacker Innovation Award winners announced Alexander Wacker Innovation Award winners announced Team of three takes €10,000 prize for pioneering work on Esetec secretion system Novavax makes two management promotions Novavax makes two management promotions In legal affairs and global programme management Paul Rice to head EMEA region for Marken Paul Rice to head EMEA region for Marken Brings 23 years of logistics and pharmaceutical experience to the company Medivation makes change to executive management team Medivation makes change to executive management team Dawn Svoronos becomes interim Chief Commercial Officer while company searches for permanent candidate Vertex’ VP of Global R&D and CSO to retire Vertex’ VP of Global R&D and CSO to retire Peter Mueller joined the company in 2003 Midatech appoints Nick Robbins-Cherry as Finance Director Midatech appoints Nick Robbins-Cherry as Finance Director Strengthening the senior management team at the nanomedicines specialist Retrogenix appoints Matthew Britz to lead North American business development activities Retrogenix appoints Matthew Britz to lead North American business development activities Follows increased demand for company\'s technology in the area of target deconvolution Two new managers join Clondalkin Group Two new managers join Clondalkin Group With a combined experience of 55 years in the packaging sector Luciano Rossetti to become EVP of R&D at Merck Serono Luciano Rossetti to become EVP of R&D at Merck Serono Takes up the position, based in Billerica, MA, US on 21 July Tadahiro Matsumura joins Catalent as Country Leader in Japan Tadahiro Matsumura joins Catalent as Country Leader in Japan Will drive growth through business development in Japan and the surrounding area Oxford BioTherapeutics hires Head of Clinical Development Oxford BioTherapeutics hires Head of Clinical Development Dr Eugen Leo takes the position Mitie Group appoints manufacturing specialist for its Environmental+ business Mitie Group appoints manufacturing specialist for its Environmental+ business Gareth Smallman becomes Director of Manufacturing, Industrial and Specialist Services Biotec Services appoints Martin Lamb as Commercial Director Biotec Services appoints Martin Lamb as Commercial Director He has more than 20 years of industry experience Winners of the Chemical Industry Awards 2014 announced Winners of the Chemical Industry Awards 2014 announced Novartis and GSK are honoured Aesica recruits Business Development Manager Aesica recruits Business Development Manager Nadine Reuter will help drive sales in Germany, Austria and Switzerland Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence Dr Sarah Harris will lead the team in San Diego C4X Discovery appoints Piers Morgan as Chief Executive C4X Discovery appoints Piers Morgan as Chief Executive Succeeds Sam Williams who returns to Non-Executive Director role Solstice Biologics expands management team following achievement of technology milestones Solstice Biologics expands management team following achievement of technology milestones Appoints Lou Tartaglia as President and CEO, while John Borgeson joins as CFO Robbie Stewart and Jen Doody join PCI UK team Robbie Stewart and Jen Doody join PCI UK team New appointments in Business Development and Human Resource Management Oxford BioTherapeutics appoints Chief Scientific Officer Oxford BioTherapeutics appoints Chief Scientific Officer Dr Keith Wilson joins the company from AbbVie ViroCyt strengthens management team ViroCyt strengthens management team Cellular and molecular immunologist joins the company as Chief Technology Officer